Brief: Ligand Reports First Quarter 2023 Financial Results
May 4 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* LIGAND REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* 2023 FINANCIAL GUIDANCE RAISED
* NET INCOME FROM CONTINUING OPERATIONS FOR Q1 OF 2023 WAS
$2.43
PER DILUTED SHARE
* Q1 EARNINGS PER SHARE VIEW $0.89 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwq0Zkqa
Further company coverage: LGND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan